Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contraception during perimenopause.

N A Kailas1, S Sifakis, E Koumantakis

  • 1Department of Obstetrics and Gynecology, University of Crete, Heraklion, Greece.

The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|July 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Well-being among university students in the post-COVID-19 era: a cross-country survey.

Scientific reports·2024
Same author

Transcriptional inactivation of p53, Bax, Bcl-2 and Mdm2 correlates with malignant transformation of the uterine cervix.

The International journal of biological markers·2017
Same author

Endometriosis and breast cancer: A survey of the epidemiological studies.

Oncology letters·2016
Same author

Role of the angiopoietin/Tie system in pregnancy (Review).

Experimental and therapeutic medicine·2015
Same author

Placental mRNA expression of angiopoietins (Ang)-1, Ang-2 and their receptor Tie-2 is altered in pregnancies complicated by preeclampsia.

Placenta·2014
Same author

Dialkyl phosphates in amniotic fluid as a biomarker of fetal exposure to organophosphates in Crete, Greece; association with fetal growth.

Reproductive toxicology (Elmsford, N.Y.)·2014
Same journal

Dissociation of gonadal and adrenal androgens one year after etonogestrel implant insertion.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
Same journal

A titrated low-dose misoprostol protocol for second-trimester abortion (13-26 weeks) in women with one prior cesarean and preterm premature rupture of membranes: a clinical practice report.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
Same journal

Factors associated with unplanned pregnancy among pregnant female adolescents in the Southeast region of Brazil: a cross-sectional study.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
Same journal

Contraceptive effectiveness of a digital contraceptive with a wearable device vs an oral thermometer.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
Same journal

Fertile-window misclassification in period-tracking applications and associated pregnancy risk: a large observational analysis.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
Same journal

Measurement of pain during first trimester medical abortion: an exploratory qualitative study.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
See all related articles

Women in perimenopause need effective contraception despite declining fertility. Careful consideration of health issues and contraceptive options is crucial for safe and suitable choices.

Area of Science:

  • Reproductive Endocrinology
  • Gynecology
  • Family Planning

Background:

  • Perimenopause is a transitional phase characterized by declining ovarian function and irregular ovulation.
  • Fertility significantly decreases in the mid-forties, yet effective contraception remains essential for women during this period.
  • Perimenopausal health concerns, including menstrual irregularities, vasomotor symptoms, and increased risks of osteoporosis, cardiovascular disease, and gynecological cancer, influence contraceptive choices.

Purpose of the Study:

  • To review contraceptive options for women experiencing perimenopause.
  • To highlight the importance of considering individual health factors and contraceptive needs in this age group.
  • To discuss the benefits and risks associated with various contraceptive methods during perimenopause.

Related Experiment Videos

Main Methods:

  • Review of existing literature on contraception for perimenopausal women.
  • Analysis of current contraceptive methods, including traditional and newer options.
  • Consideration of health issues pertinent to perimenopausal women.

Main Results:

  • Established contraceptive methods like oral contraceptives, IUDs, and barrier methods are available.
  • Newer methods such as monthly injectables, vaginal rings, and transdermal systems offer high efficacy and potentially fewer side effects.
  • Further research is needed to confirm the safety and efficacy of newer contraceptive methods specifically in the perimenopausal population.

Conclusions:

  • Contraceptive selection during perimenopause requires a careful balance of benefits and risks.
  • Individualized counseling is essential to align contraceptive choices with women's specific health profiles and needs.
  • Ongoing research is necessary to fully establish the role of novel contraceptive technologies in perimenopausal family planning.